The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODOJapanese team proves iPS-based cornea transplant safe in world-1st trial
OSAKA©2024 GPlusMedia Inc.
The requested article has expired, and is no longer available. Any related articles, and user comments are shown below.
© KYODO
6 Comments
Login to comment
virusrex
Immunologically speaking the eye is a very promising field for trials of iPS cell based treatments, so it may be too optimistic to expect this to be followed by similar results in other organs and diseaes, but for patients with ocular diseases this is very positive. Even if the full mechanism of the treatment is not well characterized being able to have differences in the treated patients is enough to give hope to countless people affected and that until now had no treatment available.
PTownsend
Great news! Congratulations to all involved!
Here's hoping Japanese universities and corporations put greater emphasis on medical research and medical technology.
Kyo wa heiwa dayo ne
And all saw improvements.
This is good .
Rodney
Great day today. The first story I read and it is jolly good news. And it’s sunny outside.
Spitfire
Well done indeed.
Much respect to them.
Mickelicious
Excellent! Bravo!